Haemoglobin Marseille-Long Island and interpretation of HbA1c: which HbA1c result is the “right answer”?
Authors:
Open Access
- 1 March 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 79 (929) , 174-175
Abstract
A woman was screened for diabetes using glycated haemoglobin (HbA1c). Vastly different results were obtained by high performance liquid chromatography (45%), immunoassay (2.9%), and affinity chromatography (4.2%) compared with the non-diabetic range of less than 6.4%. Mass spectral studies confirmed the presence a haemoglobin variant, haemoglobin Marseille-Long Island which had confounded interpretation by all methods.Keywords
This publication has 7 references indexed in Scilit:
- Effects of Hemoglobin Variants and Chemically Modified Derivatives on Assays for GlycohemoglobinClinical Chemistry, 2001
- Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.Diabetes Care, 2000
- Another Step Toward Standardization of Methods for Measuring Hemoglobin A1cClinical Chemistry, 1997
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Hemoglobin Long Island is caused by a single mutation (adenine to cytosine) resulting in a failure to cleave amino-terminal methionine.Proceedings of the National Academy of Sciences, 1986
- Hb Marseille [α2β2 N methionyl ‐ 2 (NA2) His → Pro]: a new β chain variant having an extended N‐terminusFEBS Letters, 1984
- Fructosamine: A new approach to the estimation of serum glycosylprotein. An index of diabetic controlClinica Chimica Acta, 1983